首页 > 最新文献

Circulation reports最新文献

英文 中文
Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients. 野生型转甲状腺素淀粉样心肌病患者停用他法非地。
IF 1.1 Pub Date : 2025-10-11 eCollection Date: 2025-12-10 DOI: 10.1253/circrep.CR-25-0181
Yuichi Baba, Yuri Ochi, Toru Kubo, Juri Kawaguchi, Naohito Yamasaki, Hiroaki Kitaoka

Background: The optimal period for discontinuing tafamidis in wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) patients based on cost-effectiveness is unknown.

Methods and results: A retrospective analysis of 80 tafamidis-treated ATTRwt-CM patients was conducted. The median follow up was 26.4 months; 17 patients permanently discontinued tafamidis, and 12 patients died after a median of 1.0 month following tafamidis discontinuation. Discontinuation was mainly due to non-cardiovascular hospitalization; deaths were mostly non-cardiovascular and occurred early after discontinuation.

Conclusions: The period from tafamidis discontinuation to death was shorter in ATTRwt-CM patients hospitalized for non-cardiovascular diseases. Discussions of the right period for discontinuation are needed.

背景:基于成本-效果的野生型转甲状腺素淀粉样心肌病(ATTRwt-CM)患者停药的最佳时间尚不清楚。方法与结果:对80例经他非他汀治疗的attrt - cm患者进行回顾性分析。中位随访时间为26.4个月;17例患者永久停用他法底斯,12例患者在他法底斯停用后中位1.0个月死亡。停药主要是由于非心血管住院;死亡主要是非心血管疾病,发生在停药后早期。结论:因非心血管疾病住院的attrt - cm患者从停药到死亡的时间较短。有必要讨论停止的适当时期。
{"title":"Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients.","authors":"Yuichi Baba, Yuri Ochi, Toru Kubo, Juri Kawaguchi, Naohito Yamasaki, Hiroaki Kitaoka","doi":"10.1253/circrep.CR-25-0181","DOIUrl":"10.1253/circrep.CR-25-0181","url":null,"abstract":"<p><strong>Background: </strong>The optimal period for discontinuing tafamidis in wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) patients based on cost-effectiveness is unknown.</p><p><strong>Methods and results: </strong>A retrospective analysis of 80 tafamidis-treated ATTRwt-CM patients was conducted. The median follow up was 26.4 months; 17 patients permanently discontinued tafamidis, and 12 patients died after a median of 1.0 month following tafamidis discontinuation. Discontinuation was mainly due to non-cardiovascular hospitalization; deaths were mostly non-cardiovascular and occurred early after discontinuation.</p><p><strong>Conclusions: </strong>The period from tafamidis discontinuation to death was shorter in ATTRwt-CM patients hospitalized for non-cardiovascular diseases. Discussions of the right period for discontinuation are needed.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 12","pages":"1301-1303"},"PeriodicalIF":1.1,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145728044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Placement of the Coronary Sinus Catheter via the Right Cubital Vein During Atrial Fibrillation Ablation. 房颤消融过程中经右肘静脉置入冠状窦导管。
IF 1.1 Pub Date : 2025-10-11 eCollection Date: 2025-12-10 DOI: 10.1253/circrep.CR-25-0187
Kohei Iwasa, Masato Okada, Koji Tanaka, Yuko Hirao, Naoko Miyazaki, Heitaro Watanabe, Yoshitaka Iwanaga, Atsunori Okamura, Yasushi Sakata, Nobuaki Tanaka

Background: Electrode catheter placement into the coronary sinus (CS) is critical for electrophysiologic studies. Although central venous approaches (e.g., internal jugular or subclavian) are well documented, peripheral venous approaches like the cubital vein are not. This study evaluated the feasibility and safety of CS catheter placement via the right cubital vein during atrial fibrillation (AF) ablation.

Methods and results: Of 1,363 consecutive patients who underwent first-time AF ablation at Sakurabashi Watanabe Advanced Healthcare Hospital between January 2019 and December 2021, 1,274 underwent at least 1 right cubital vein puncture attempt. The success rate, causes of failure, and complications were analyzed. CS catheters were successfully placed via the right cubital vein in 1,214 (95.3%) patients, whereas placements were unsuccessful in 60 (4.7%) patients. Although older patients were more likely to experience unsuccessful placements, there were no significant differences in other baseline characteristics between the 2 groups. Unsuccessful placements were attributed to failure in venipuncture or sheath insertion (n=49) and failure to advance the CS catheter through the vein (n=11). No major complications were reported.

Conclusions: CS catheter placement via the right cubital vein demonstrated high feasibility and safety, with a 95% success rate and minimal complications. This approach offers a practical and technically straightforward alternative for placing CS catheters, particularly in patients with adequate vein development.

背景:电极导管置入冠状窦(CS)是电生理研究的关键。虽然中心静脉入路(如颈内静脉或锁骨下静脉)有很好的文献记载,但像肘静脉这样的外周静脉入路却没有。本研究评估心房颤动(AF)消融过程中经右肘静脉置管的可行性和安全性。方法和结果:2019年1月至2021年12月期间,在渡边樱桥高级医疗医院连续1363例首次房颤消融患者中,1274例至少进行了一次右肘静脉穿刺尝试。分析手术成功率、失败原因及并发症。1214例(95.3%)患者成功通过右肘静脉放置CS导管,60例(4.7%)患者放置失败。虽然老年患者更有可能经历不成功的安置,但两组之间的其他基线特征没有显着差异。放置失败的原因是静脉穿刺或鞘插入失败(n=49), CS导管未能通过静脉推进(n=11)。无重大并发症报道。结论:经右肘静脉置管具有较高的可行性和安全性,成功率95%,并发症极少。这种方法为放置CS导管提供了一种实用且技术上简单的选择,特别是在静脉发育充分的患者中。
{"title":"Placement of the Coronary Sinus Catheter via the Right Cubital Vein During Atrial Fibrillation Ablation.","authors":"Kohei Iwasa, Masato Okada, Koji Tanaka, Yuko Hirao, Naoko Miyazaki, Heitaro Watanabe, Yoshitaka Iwanaga, Atsunori Okamura, Yasushi Sakata, Nobuaki Tanaka","doi":"10.1253/circrep.CR-25-0187","DOIUrl":"10.1253/circrep.CR-25-0187","url":null,"abstract":"<p><strong>Background: </strong>Electrode catheter placement into the coronary sinus (CS) is critical for electrophysiologic studies. Although central venous approaches (e.g., internal jugular or subclavian) are well documented, peripheral venous approaches like the cubital vein are not. This study evaluated the feasibility and safety of CS catheter placement via the right cubital vein during atrial fibrillation (AF) ablation.</p><p><strong>Methods and results: </strong>Of 1,363 consecutive patients who underwent first-time AF ablation at Sakurabashi Watanabe Advanced Healthcare Hospital between January 2019 and December 2021, 1,274 underwent at least 1 right cubital vein puncture attempt. The success rate, causes of failure, and complications were analyzed. CS catheters were successfully placed via the right cubital vein in 1,214 (95.3%) patients, whereas placements were unsuccessful in 60 (4.7%) patients. Although older patients were more likely to experience unsuccessful placements, there were no significant differences in other baseline characteristics between the 2 groups. Unsuccessful placements were attributed to failure in venipuncture or sheath insertion (n=49) and failure to advance the CS catheter through the vein (n=11). No major complications were reported.</p><p><strong>Conclusions: </strong>CS catheter placement via the right cubital vein demonstrated high feasibility and safety, with a 95% success rate and minimal complications. This approach offers a practical and technically straightforward alternative for placing CS catheters, particularly in patients with adequate vein development.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 12","pages":"1181-1189"},"PeriodicalIF":1.1,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145728026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should Sedative Administration Be Recommended as an Antiarrhythmic Therapy to Suppress Ventricular Fibrillation and Ventricular Tachycardia in Patients With Electrical Storm? - A Scoping Review. 是否应该推荐镇静剂作为一种抗心律失常治疗来抑制电风暴患者的心室颤动和室性心动过速?-范围审查。
IF 1.1 Pub Date : 2025-10-07 eCollection Date: 2025-12-10 DOI: 10.1253/circrep.CR-25-0176
Takayuki Kitai, Tetsuma Kawaji, Yukio Hosaka, Mutsuko Sangawa, Hiroki Shiomi, Eiji Hiraoka, Kazuo Sakamoto, Kenichi Iijima, Masashi Yokose, Teruo Noguchi, Hiroshi Takahashi, Tetsuya Matoba, Migaku Kikuchi, Yoshio Tahara, Hiroshi Nonogi, Toshikazu Funazaki

Background: Electrical storm (ES) is defined as a condition in which ventricular tachycardia (VT) or ventricular fibrillation (VF) episodes requiring electrical shock or implantable cardioverter-defibrillator (ICD) shocks occur ≥3 times within 24 h. It is a life-threatening condition, and treatment options include antiarrhythmic drugs, sedation, circulatory support, and catheter ablation. Sedation is conventionally performed for repeated electrical shocks; however, evidence for its effectiveness in ES suppression remains limited. This scoping review aimed to assess whether the use of sedatives is beneficial for ES suppression.

Methods and results: This scoping review followed the PRISMA extension for scoping reviews (PRISMA-ScR) guidelines. Three online databases were searched to identify studies published from the inception of each database until September 18, 2024. To date, no randomized or quasi-randomized controlled trials or observational analytical studies have met the inclusion criteria for the use of sedation in patients with ES.

Conclusions: This scoping review underscores the need for high-quality studies to enhance the level of evidence and bridge knowledge gaps, ultimately aiming to shift the care paradigm for patients with ES.

背景:电风暴(Electrical storm, ES)被定义为室性心动过速(VT)或心室颤动(VF)发作需要电击或植入式心律转复除颤器(ICD)电击在24小时内发生≥3次。这是一种危及生命的疾病,治疗方案包括抗心律失常药物、镇静、循环支持和导管消融。镇静通常用于反复电击;然而,其抑制ES有效性的证据仍然有限。本综述旨在评估使用镇静剂是否有利于抑制ES。方法和结果:该范围审查遵循PRISMA范围审查扩展(PRISMA- scr)指南。检索了三个在线数据库,以确定从每个数据库建立到2024年9月18日发表的研究。迄今为止,没有随机或准随机对照试验或观察性分析研究符合ES患者使用镇静的纳入标准。结论:这一范围综述强调需要高质量的研究来提高证据水平和弥合知识差距,最终旨在改变ES患者的护理模式。
{"title":"Should Sedative Administration Be Recommended as an Antiarrhythmic Therapy to Suppress Ventricular Fibrillation and Ventricular Tachycardia in Patients With Electrical Storm? - A Scoping Review.","authors":"Takayuki Kitai, Tetsuma Kawaji, Yukio Hosaka, Mutsuko Sangawa, Hiroki Shiomi, Eiji Hiraoka, Kazuo Sakamoto, Kenichi Iijima, Masashi Yokose, Teruo Noguchi, Hiroshi Takahashi, Tetsuya Matoba, Migaku Kikuchi, Yoshio Tahara, Hiroshi Nonogi, Toshikazu Funazaki","doi":"10.1253/circrep.CR-25-0176","DOIUrl":"10.1253/circrep.CR-25-0176","url":null,"abstract":"<p><strong>Background: </strong>Electrical storm (ES) is defined as a condition in which ventricular tachycardia (VT) or ventricular fibrillation (VF) episodes requiring electrical shock or implantable cardioverter-defibrillator (ICD) shocks occur ≥3 times within 24 h. It is a life-threatening condition, and treatment options include antiarrhythmic drugs, sedation, circulatory support, and catheter ablation. Sedation is conventionally performed for repeated electrical shocks; however, evidence for its effectiveness in ES suppression remains limited. This scoping review aimed to assess whether the use of sedatives is beneficial for ES suppression.</p><p><strong>Methods and results: </strong>This scoping review followed the PRISMA extension for scoping reviews (PRISMA-ScR) guidelines. Three online databases were searched to identify studies published from the inception of each database until September 18, 2024. To date, no randomized or quasi-randomized controlled trials or observational analytical studies have met the inclusion criteria for the use of sedation in patients with ES.</p><p><strong>Conclusions: </strong>This scoping review underscores the need for high-quality studies to enhance the level of evidence and bridge knowledge gaps, ultimately aiming to shift the care paradigm for patients with ES.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 12","pages":"1149-1153"},"PeriodicalIF":1.1,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproducibility and Validity of a Food Intake Survey Developed for Implementation via Digital Health for Patients With or at Risk for Cardiovascular Disease. 通过数字健康为心血管疾病患者或有心血管疾病风险的患者开发的食物摄入调查的可重复性和有效性
IF 1.1 Pub Date : 2025-10-04 eCollection Date: 2025-11-10 DOI: 10.1253/circrep.CR-25-0032
Daisuke Moriyama, Takuji Adachi, Kuya Funaki, Hironobu Ashikawa, Ken Harada, Sumio Yamada

Background: We developed the SaFIS, a structured self-administered food intake survey for patients with cardiovascular diseases needing dietary improvements.

Methods and results: The SaFIS comprised questions on 31 items, including staple foods (7 items) and food ingredients (24 items), based on the foods recommended by the Japanese Atherosclerosis Society for the Prevention of Arteriosclerotic Disease. To evaluate reproducibility, SaFIS was administered twice with a 1-month interval using the intraclass correlation coefficient (ICC [1,1]). Validity was assessed by comparing energy and nutrient content from a weighed dietary record (WDR) with the first SaFIS survey using Bland-Altman plots. Reproducibility values were energy (ICC 0.90, 95% confidence interval: 0.80-0.95), protein (0.90, 0.80-0.95), fat (0.76, 0.54-0.88), saturated fatty acids (0.78, 0.58-0.89), monounsaturated fatty acids (0.76, 0.56-0.88), polyunsaturated fatty acids (0.82, 0.66-0.91), carbohydrates (0.89, 0.79-0.95), and dietary fiber (0.86, 0.71-0.93). Bland-Altman values indicated SaFIS-based energy, protein, carbohydrate, monounsaturated fatty acids, and dietary fiber were 67.2 kJ, 5.7 g, 3.9 g, 0.5 g, and 1.8 g greater than WDR-based values, respectively. SaFIS-based fat, saturated, and polyunsaturated fatty acid values were 0.7 g, 1.3 g, and 0.39 g less than WDR-based values, respectively.

Conclusions: SaFIS demonstrated high reproducibility and validity with clinical potential. Subsequent introduction to digital health from the usability perspective is planned.

背景:我们开发了SaFIS,一种结构化的自我管理的食物摄入调查,用于需要改善饮食的心血管疾病患者。方法和结果:SaFIS根据日本动脉粥样硬化协会为预防动脉硬化疾病推荐的食物,包括主食(7项)和食品成分(24项)等31项问题。为了评估再现性,使用类内相关系数(ICC[1,1]),每隔1个月给药2次SaFIS。采用Bland-Altman图将称重膳食记录(WDR)的能量和营养成分含量与首次SaFIS调查进行比较,以评估有效性。重复性值分别为能量(ICC为0.90,95%可信区间为0.80 ~ 0.95)、蛋白质(0.90、0.80 ~ 0.95)、脂肪(0.76、0.54 ~ 0.88)、饱和脂肪酸(0.78、0.58 ~ 0.89)、单不饱和脂肪酸(0.76、0.56 ~ 0.88)、多不饱和脂肪酸(0.82、0.66 ~ 0.91)、碳水化合物(0.89、0.79 ~ 0.95)和膳食纤维(0.86、0.71 ~ 0.93)。Bland-Altman值表明,基于safis的能量、蛋白质、碳水化合物、单不饱和脂肪酸和膳食纤维分别比基于wdr的值高67.2 kJ、5.7 g、3.9 g、0.5 g和1.8 g。基于safis的脂肪、饱和脂肪酸和多不饱和脂肪酸值分别比基于wdr的值低0.7 g、1.3 g和0.39 g。结论:SaFIS具有较高的重现性和有效性,具有临床应用潜力。随后将从可用性角度介绍数字健康。
{"title":"Reproducibility and Validity of a Food Intake Survey Developed for Implementation via Digital Health for Patients With or at Risk for Cardiovascular Disease.","authors":"Daisuke Moriyama, Takuji Adachi, Kuya Funaki, Hironobu Ashikawa, Ken Harada, Sumio Yamada","doi":"10.1253/circrep.CR-25-0032","DOIUrl":"10.1253/circrep.CR-25-0032","url":null,"abstract":"<p><strong>Background: </strong>We developed the SaFIS, a structured self-administered food intake survey for patients with cardiovascular diseases needing dietary improvements.</p><p><strong>Methods and results: </strong>The SaFIS comprised questions on 31 items, including staple foods (7 items) and food ingredients (24 items), based on the foods recommended by the Japanese Atherosclerosis Society for the Prevention of Arteriosclerotic Disease. To evaluate reproducibility, SaFIS was administered twice with a 1-month interval using the intraclass correlation coefficient (ICC [1,1]). Validity was assessed by comparing energy and nutrient content from a weighed dietary record (WDR) with the first SaFIS survey using Bland-Altman plots. Reproducibility values were energy (ICC 0.90, 95% confidence interval: 0.80-0.95), protein (0.90, 0.80-0.95), fat (0.76, 0.54-0.88), saturated fatty acids (0.78, 0.58-0.89), monounsaturated fatty acids (0.76, 0.56-0.88), polyunsaturated fatty acids (0.82, 0.66-0.91), carbohydrates (0.89, 0.79-0.95), and dietary fiber (0.86, 0.71-0.93). Bland-Altman values indicated SaFIS-based energy, protein, carbohydrate, monounsaturated fatty acids, and dietary fiber were 67.2 kJ, 5.7 g, 3.9 g, 0.5 g, and 1.8 g greater than WDR-based values, respectively. SaFIS-based fat, saturated, and polyunsaturated fatty acid values were 0.7 g, 1.3 g, and 0.39 g less than WDR-based values, respectively.</p><p><strong>Conclusions: </strong>SaFIS demonstrated high reproducibility and validity with clinical potential. Subsequent introduction to digital health from the usability perspective is planned.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 11","pages":"1109-1115"},"PeriodicalIF":1.1,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resuscitation Training Amid the Coronavirus Disease 2019 Pandemic - A Safe Approach. 2019冠状病毒大流行期间的复苏培训-一种安全的方法。
IF 1.1 Pub Date : 2025-10-04 eCollection Date: 2025-12-10 DOI: 10.1253/circrep.CR-25-0164
Yukio Shiina, Atsuhito Fukushima, Migaku Kikuchi

Background: This study retrospectively evaluated the safety of resuscitation training during the Coronavirus Disease 2019 (COVID-19) pandemic under Japan Resuscitation Council (JRC) guidance.

Methods and results: From 2018 to 2024, all participating staff were monitored by the Infection Prevention and Control Center. Although learner numbers declined in 2020, training sessions increased, and numbers returned to prepandemic levels. The Resuscitation Quality Improvement program enabled flexible, contactless training, further boosting participation. Notably, no COVID-19 cases were linked to training sessions.

Conclusions: These findings demonstrate that resuscitation training can be conducted safely by adhering to JRC guidance, even during a public health crisis.

背景:本研究在日本复苏委员会(JRC)的指导下,回顾性评估了2019冠状病毒病(COVID-19)大流行期间复苏培训的安全性。方法与结果:2018 - 2024年,由感染预防控制中心对所有参与人员进行监测。尽管2020年学员人数有所下降,但培训课程有所增加,数量恢复到大流行前的水平。复苏质量改进计划实现了灵活的非接触式培训,进一步提高了参与程度。值得注意的是,没有一例COVID-19病例与培训有关。结论:这些发现表明,即使在公共卫生危机期间,坚持JRC指导也可以安全地进行复苏训练。
{"title":"Resuscitation Training Amid the Coronavirus Disease 2019 Pandemic - A Safe Approach.","authors":"Yukio Shiina, Atsuhito Fukushima, Migaku Kikuchi","doi":"10.1253/circrep.CR-25-0164","DOIUrl":"https://doi.org/10.1253/circrep.CR-25-0164","url":null,"abstract":"<p><strong>Background: </strong>This study retrospectively evaluated the safety of resuscitation training during the Coronavirus Disease 2019 (COVID-19) pandemic under Japan Resuscitation Council (JRC) guidance.</p><p><strong>Methods and results: </strong>From 2018 to 2024, all participating staff were monitored by the Infection Prevention and Control Center. Although learner numbers declined in 2020, training sessions increased, and numbers returned to prepandemic levels. The Resuscitation Quality Improvement program enabled flexible, contactless training, further boosting participation. Notably, no COVID-19 cases were linked to training sessions.</p><p><strong>Conclusions: </strong>These findings demonstrate that resuscitation training can be conducted safely by adhering to JRC guidance, even during a public health crisis.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 12","pages":"1298-1300"},"PeriodicalIF":1.1,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Optimal Amount of Cardiac Rehabilitation During Hospitalization for Recovery of Activities of Daily Living. 探索住院期间心脏康复的最佳量,以恢复日常生活活动。
IF 1.1 Pub Date : 2025-10-01 eCollection Date: 2025-11-10 DOI: 10.1253/circrep.CR-25-0203
Junichi Yokota
{"title":"Exploring the Optimal Amount of Cardiac Rehabilitation During Hospitalization for Recovery of Activities of Daily Living.","authors":"Junichi Yokota","doi":"10.1253/circrep.CR-25-0203","DOIUrl":"10.1253/circrep.CR-25-0203","url":null,"abstract":"","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 11","pages":"1060-1061"},"PeriodicalIF":1.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Cardiac Rehabilitation and Recovery From Decline in Activities of Daily Living in Patients Hospitalized With Cardiovascular Disease. 心血管疾病住院患者日常生活能力下降与心脏康复的关系
IF 1.1 Pub Date : 2025-10-01 eCollection Date: 2025-11-10 DOI: 10.1253/circrep.CR-25-0024
Masami Kimura, Masataka Nakano, Chie Shiraishi, Shota Onoda, Takashi Amari, Kento Ihara, Kentaro Watanabe, Sayuri Tanaka, Takaaki Isshiki

Background: Decline or inadequate recovery of activities of daily living (ADL) during hospitalization is crucial for clinical prognosis. In this study we investigated the relationship between cardiac rehabilitation (CR) and ADL recovery in patients with cardiovascular disease (CVD), with the aim of exploring associations that may contribute to the development of rehabilitation interventions.

Methods and results: This study analyzed consecutive patients hospitalized with CVD. ADL was assessed using the Barthel index (BI) at the commencement of rehabilitation and discharge. As the outcome measure for ADL, relative functional gain: BI effectiveness, calculated as (discharge BI - initial BI) / (100 - initial BI), was adopted in order to compensate ceiling effect of BI. BI effectiveness ≥0.5 defined the ADL recovery group, while <0.5 defined the ADL non-recovery group. Of the 2,938 patients screened, 1,582 (median age 79 years, male 59%) were included after exclusions. The ADL recovery group consisted of 1,162 patients, the ADL non-recovery group, 420 patients. Between-group comparisons and multivariate regression analysis identified age and initial BI as highly significant ADL recovery determinants. Recursive partitioning analysis showed CR volumes of ≥75 min/day for patients ≥75 years and ≥45 min/day for those <75 years with lower initial BI were associated with ADL recovery. These CR volumes also reduced the institutionalization odds ratios (OR=0.42 and OR=0.34, P<0.001) compared to CR volumes <45 min/day.

Conclusions: CR volume was associated with ADL recovery, especially for older patients with low baseline function at admission. Optimizing CR volume based on patient background and condition may contribute to enhance ADL recovery and improved clinical prognosis.

背景:住院期间日常生活活动能力(ADL)下降或恢复不足对临床预后至关重要。在本研究中,我们研究了心血管疾病(CVD)患者心脏康复(CR)与ADL恢复之间的关系,目的是探索可能有助于康复干预措施发展的关联。方法和结果:本研究分析了连续住院的心血管疾病患者。在康复开始和出院时采用Barthel指数(BI)评估ADL。作为ADL的结局指标,采用相对功能增益:BI有效性,计算为(放电BI -初始BI) /(100 -初始BI),以补偿BI的天花板效应。BI有效性≥0.5定义为ADL恢复组,结论:CR容量与ADL恢复相关,特别是对于入院时基线功能较低的老年患者。根据患者的背景和条件优化CR容量可能有助于提高ADL的恢复和改善临床预后。
{"title":"Relationship Between Cardiac Rehabilitation and Recovery From Decline in Activities of Daily Living in Patients Hospitalized With Cardiovascular Disease.","authors":"Masami Kimura, Masataka Nakano, Chie Shiraishi, Shota Onoda, Takashi Amari, Kento Ihara, Kentaro Watanabe, Sayuri Tanaka, Takaaki Isshiki","doi":"10.1253/circrep.CR-25-0024","DOIUrl":"10.1253/circrep.CR-25-0024","url":null,"abstract":"<p><strong>Background: </strong>Decline or inadequate recovery of activities of daily living (ADL) during hospitalization is crucial for clinical prognosis. In this study we investigated the relationship between cardiac rehabilitation (CR) and ADL recovery in patients with cardiovascular disease (CVD), with the aim of exploring associations that may contribute to the development of rehabilitation interventions.</p><p><strong>Methods and results: </strong>This study analyzed consecutive patients hospitalized with CVD. ADL was assessed using the Barthel index (BI) at the commencement of rehabilitation and discharge. As the outcome measure for ADL, relative functional gain: BI effectiveness, calculated as (discharge BI - initial BI) / (100 - initial BI), was adopted in order to compensate ceiling effect of BI. BI effectiveness ≥0.5 defined the ADL recovery group, while <0.5 defined the ADL non-recovery group. Of the 2,938 patients screened, 1,582 (median age 79 years, male 59%) were included after exclusions. The ADL recovery group consisted of 1,162 patients, the ADL non-recovery group, 420 patients. Between-group comparisons and multivariate regression analysis identified age and initial BI as highly significant ADL recovery determinants. Recursive partitioning analysis showed CR volumes of ≥75 min/day for patients ≥75 years and ≥45 min/day for those <75 years with lower initial BI were associated with ADL recovery. These CR volumes also reduced the institutionalization odds ratios (OR=0.42 and OR=0.34, P<0.001) compared to CR volumes <45 min/day.</p><p><strong>Conclusions: </strong>CR volume was associated with ADL recovery, especially for older patients with low baseline function at admission. Optimizing CR volume based on patient background and condition may contribute to enhance ADL recovery and improved clinical prognosis.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 11","pages":"1051-1059"},"PeriodicalIF":1.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597247/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long Inflation at Stent Deployment in Intravascular Ultrasound-Guided Percutaneous Coronary Intervention for Acute Myocardial Infarction. 超声引导下经皮冠状动脉介入治疗急性心肌梗死时支架放置时的长时间膨胀。
IF 1.1 Pub Date : 2025-09-30 eCollection Date: 2025-12-10 DOI: 10.1253/circrep.CR-25-0141
Yusuke Watanabe, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Masaru Seguchi, Takunori Tsukui, Taku Kasahara, Masashi Hatori, Shun Ishibashi, Hideo Fujita

Background: There is a substantial risk of slow flow during percutaneous coronary intervention (PCI) for the culprit lesion in acute myocardial infarction (AMI), which can lead to adverse outcomes. We hypothesized that single-step long balloon inflation during stent deployment was associated with a more favorable final Thrombolysis in Myocardial Infarction (TIMI) flow grade. This retrospective study aimed to compare both the final TIMI flow grade and the delta TIMI flow grade in intravascular ultrasound (IVUS)-guided PCI for AMI between patients with long balloon inflation and those with conventional inflation.

Methods and results: Long inflation was defined as single-step inflation ≥60 s at stent deployment. The primary endpoints were achievement of the final TIMI flow grade 3 and the delta TIMI flow grade, defined as the difference between the initial and final grades. We analyzed 336 AMI patients with attenuation plaque on IVUS, dividing them into a long inflation group (n=50) and a conventional inflation group (n=286). Despite a significantly higher TIMI thrombus grade in the long inflation group (P<0.001), the rate of the final TIMI 3 flow was similar (90% vs. 88.5%; P=1.00). However, the delta TIMI flow grade was significantly greater in the long inflation group (P=0.028).

Conclusions: Single-step long balloon inflation may be a simple and feasible method to achieve optimal final TIMI flow in IVUS-guided PCI for AMI.

背景:对于急性心肌梗死(AMI)的罪魁祸首病变,经皮冠状动脉介入治疗(PCI)存在很大的慢血流风险,这可能导致不良后果。我们假设支架部署期间的单步长球囊膨胀与更有利的最终心肌梗死溶栓(TIMI)血流等级相关。本回顾性研究旨在比较血管内超声(IVUS)引导下AMI长球囊充气患者和常规充气患者的最终TIMI血流等级和delta TIMI血流等级。方法与结果:长期膨胀定义为支架放置时单步膨胀≥60 s。主要终点是达到最终的TIMI流量等级3和delta TIMI流量等级,定义为初始和最终等级之间的差异。我们分析了336例IVUS上有衰减斑块的AMI患者,将其分为长膨胀组(n=50)和常规膨胀组(n=286)。结论:单步长球囊充气可能是ivus引导下AMI PCI最终达到最佳TIMI流量的一种简单可行的方法。
{"title":"Long Inflation at Stent Deployment in Intravascular Ultrasound-Guided Percutaneous Coronary Intervention for Acute Myocardial Infarction.","authors":"Yusuke Watanabe, Kenichi Sakakura, Hiroyuki Jinnouchi, Yousuke Taniguchi, Kei Yamamoto, Masaru Seguchi, Takunori Tsukui, Taku Kasahara, Masashi Hatori, Shun Ishibashi, Hideo Fujita","doi":"10.1253/circrep.CR-25-0141","DOIUrl":"10.1253/circrep.CR-25-0141","url":null,"abstract":"<p><strong>Background: </strong>There is a substantial risk of slow flow during percutaneous coronary intervention (PCI) for the culprit lesion in acute myocardial infarction (AMI), which can lead to adverse outcomes. We hypothesized that single-step long balloon inflation during stent deployment was associated with a more favorable final Thrombolysis in Myocardial Infarction (TIMI) flow grade. This retrospective study aimed to compare both the final TIMI flow grade and the delta TIMI flow grade in intravascular ultrasound (IVUS)-guided PCI for AMI between patients with long balloon inflation and those with conventional inflation.</p><p><strong>Methods and results: </strong>Long inflation was defined as single-step inflation ≥60 s at stent deployment. The primary endpoints were achievement of the final TIMI flow grade 3 and the delta TIMI flow grade, defined as the difference between the initial and final grades. We analyzed 336 AMI patients with attenuation plaque on IVUS, dividing them into a long inflation group (n=50) and a conventional inflation group (n=286). Despite a significantly higher TIMI thrombus grade in the long inflation group (P<0.001), the rate of the final TIMI 3 flow was similar (90% vs. 88.5%; P=1.00). However, the delta TIMI flow grade was significantly greater in the long inflation group (P=0.028).</p><p><strong>Conclusions: </strong>Single-step long balloon inflation may be a simple and feasible method to achieve optimal final TIMI flow in IVUS-guided PCI for AMI.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 12","pages":"1230-1239"},"PeriodicalIF":1.1,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Annual Changes in the Geriatric Nutritional Risk Index in Malnourished Patients With Heart Failure. 营养不良合并心力衰竭患者老年营养风险指数年度变化对预后的影响
IF 1.1 Pub Date : 2025-09-30 eCollection Date: 2025-12-10 DOI: 10.1253/circrep.CR-25-0177
Tatsuya Kitagawa, Wataru Fujimoto, Makoto Takemoto, Koji Kuroda, Soichiro Yamashita, Junichi Imanishi, Masamichi Iwasaki, Takafumi Todoroki, Masanori Okuda, Manabu Nagao, Akihide Konishi, Ryuji Toh, Kunihiro Nishimura, Masakazu Shinohara, Hiromasa Otake

Background: Malnutrition is a significant prognostic factor in chronic heart failure (CHF), particularly among older adults. The geriatric nutritional risk index (GNRI) is a screening tool for assessing malnutrition in this population. Although low GNRI is associated with increased deaths of patients with HF, the prognostic impact of longitudinal GNRI changes in malnourished patients remains unclear.

Methods and results: This post-hoc analysis of the KUNIUMI registry chronic cohort, a prospective observational study of patients with pre-HF/HF, assessed GNRI at baseline and 1-year follow-up. The annual GNRI change (∆GNRI) was calculated, and its association with all-cause death in malnourished patients was analyzed. The primary outcome was all-cause death, with a 2-year follow-up after the initial 1-year assessment. Among 1,242 patients (mean age: 74.4±10.9 years), 19.8% had low GNRI (<92). All-cause death was significantly higher in patients with low GNRI than in those with high GNRI (30.1% vs. 7.1%; P<0.001). In patients with low GNRI, multivariable Cox regression showed a significant association between ∆GNRI and death (hazard ratio: 0.94; 95% confidence interval: 0.91-0.96; P<0.001). Multiple linear regression indicated that nutritional counseling positively influenced ∆GNRI, but HF severity was not significantly associated.

Conclusions: ∆GNRI is a significant prognostic indicator in malnourished patients with pre-HF/HF. Serial GNRI assessments may improve risk stratification and guide nutritional interventions.

背景:营养不良是慢性心力衰竭(CHF)的一个重要预后因素,尤其是在老年人中。老年人营养风险指数(GNRI)是评估这一人群营养不良的筛查工具。虽然低GNRI与心衰患者死亡率增加有关,但营养不良患者的纵向GNRI变化对预后的影响尚不清楚。方法和结果:对KUNIUMI注册慢性队列进行事后分析,这是一项前瞻性观察性研究,研究对象是HF前期/HF患者,在基线和1年随访时评估GNRI。计算营养不良患者GNRI的年变化(∆GNRI),并分析其与营养不良患者全因死亡的关系。主要结局为全因死亡,在最初的1年评估后进行了2年的随访。在1242例患者(平均年龄:74.4±10.9岁)中,19.8%的患者GNRI较低(结论:∆GNRI是HF/HF前期营养不良患者的重要预后指标。连续的GNRI评估可以改善风险分层和指导营养干预。
{"title":"Prognostic Impact of Annual Changes in the Geriatric Nutritional Risk Index in Malnourished Patients With Heart Failure.","authors":"Tatsuya Kitagawa, Wataru Fujimoto, Makoto Takemoto, Koji Kuroda, Soichiro Yamashita, Junichi Imanishi, Masamichi Iwasaki, Takafumi Todoroki, Masanori Okuda, Manabu Nagao, Akihide Konishi, Ryuji Toh, Kunihiro Nishimura, Masakazu Shinohara, Hiromasa Otake","doi":"10.1253/circrep.CR-25-0177","DOIUrl":"10.1253/circrep.CR-25-0177","url":null,"abstract":"<p><strong>Background: </strong>Malnutrition is a significant prognostic factor in chronic heart failure (CHF), particularly among older adults. The geriatric nutritional risk index (GNRI) is a screening tool for assessing malnutrition in this population. Although low GNRI is associated with increased deaths of patients with HF, the prognostic impact of longitudinal GNRI changes in malnourished patients remains unclear.</p><p><strong>Methods and results: </strong>This post-hoc analysis of the KUNIUMI registry chronic cohort, a prospective observational study of patients with pre-HF/HF, assessed GNRI at baseline and 1-year follow-up. The annual GNRI change (∆GNRI) was calculated, and its association with all-cause death in malnourished patients was analyzed. The primary outcome was all-cause death, with a 2-year follow-up after the initial 1-year assessment. Among 1,242 patients (mean age: 74.4±10.9 years), 19.8% had low GNRI (<92). All-cause death was significantly higher in patients with low GNRI than in those with high GNRI (30.1% vs. 7.1%; P<0.001). In patients with low GNRI, multivariable Cox regression showed a significant association between ∆GNRI and death (hazard ratio: 0.94; 95% confidence interval: 0.91-0.96; P<0.001). Multiple linear regression indicated that nutritional counseling positively influenced ∆GNRI, but HF severity was not significantly associated.</p><p><strong>Conclusions: </strong>∆GNRI is a significant prognostic indicator in malnourished patients with pre-HF/HF. Serial GNRI assessments may improve risk stratification and guide nutritional interventions.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 12","pages":"1211-1221"},"PeriodicalIF":1.1,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12688437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145727139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial Dose of Intravenous Atropine for Patients With Symptomatic Bradycardia - A Scoping Review. 静脉注射阿托品治疗症状性心动过缓患者的初始剂量——一个范围综述。
IF 1.1 Pub Date : 2025-09-27 eCollection Date: 2025-11-10 DOI: 10.1253/circrep.CR-25-0169
Masashi Yokose, Mutsuko Sangawa, Hiroki Shiomi, Kazuo Sakamoto, Kenichi Iijima, Tetsuma Kawaji, Takayuki Kitai, Yukio Hosaka, Eiji Hiraoka, Teruo Noguchi, Hiroshi Takahashi, Tetsuya Matoba, Migaku Kikuchi, Yoshio Tahara, Hiroshi Nonogi, Toshikazu Funazaki

Intravenous atropine is widely recommended as the first-line treatment for symptomatic bradycardia, but because the optimal initial dose remains uncertain, the aim of this scoping review was to examine the existing literature on the efficacy and safety of intravenous atropine at specific doses in adult patients with symptomatic bradycardia and to identify gaps in evidence. A systematic search of 4 databases (PubMed, CENTRAL, Web of Science, and Ichushi-Web) was conducted from inception to December 16, 2024. Studies were included if they reported administration of a specified dose of atropine in adult patients, regardless of study design. No randomized controlled trials directly comparing 0.5 mg vs. 1.0 mg were found. A total of 19 studies were included and categorized into groups based on initial atropine dose: low (<0.5 mg), moderate (0.5 mg ≤ dose <1.0 mg), high (≥1.0 mg), and those spanning multiple categories. No consistent relationship was found between atropine dose and clinical outcomes, such as heart rate response or adverse effects. None of the moderate-dose studies reported worsening bradycardia. Moderate-dose atropine could be safe, and the current practice of using 0.5 mg as an initial dose in Japan, where 0.5 mg/mL prefilled syringes are commercially available, appears clinically reasonable. However, in the absence of high-quality comparative data, future research should apply rigorous study designs to determine the optimal atropine dose in emergency care settings.

静脉注射阿托品被广泛推荐作为对症性心动过缓的一线治疗,但由于最佳初始剂量仍不确定,本综述的目的是检查关于特定剂量静脉注射阿托品治疗对症性心动过缓成人患者的有效性和安全性的现有文献,并找出证据中的空白。系统检索了4个数据库(PubMed, CENTRAL, Web of Science, Ichushi-Web),从成立到2024年12月16日。无论研究设计如何,只要报告成人患者使用特定剂量的阿托品,就纳入研究。没有发现直接比较0.5 mg和1.0 mg的随机对照试验。共纳入19项研究,并根据阿托品的初始剂量分为两组:低(
{"title":"Initial Dose of Intravenous Atropine for Patients With Symptomatic Bradycardia - A Scoping Review.","authors":"Masashi Yokose, Mutsuko Sangawa, Hiroki Shiomi, Kazuo Sakamoto, Kenichi Iijima, Tetsuma Kawaji, Takayuki Kitai, Yukio Hosaka, Eiji Hiraoka, Teruo Noguchi, Hiroshi Takahashi, Tetsuya Matoba, Migaku Kikuchi, Yoshio Tahara, Hiroshi Nonogi, Toshikazu Funazaki","doi":"10.1253/circrep.CR-25-0169","DOIUrl":"10.1253/circrep.CR-25-0169","url":null,"abstract":"<p><p>Intravenous atropine is widely recommended as the first-line treatment for symptomatic bradycardia, but because the optimal initial dose remains uncertain, the aim of this scoping review was to examine the existing literature on the efficacy and safety of intravenous atropine at specific doses in adult patients with symptomatic bradycardia and to identify gaps in evidence. A systematic search of 4 databases (PubMed, CENTRAL, Web of Science, and Ichushi-Web) was conducted from inception to December 16, 2024. Studies were included if they reported administration of a specified dose of atropine in adult patients, regardless of study design. No randomized controlled trials directly comparing 0.5 mg vs. 1.0 mg were found. A total of 19 studies were included and categorized into groups based on initial atropine dose: low (<0.5 mg), moderate (0.5 mg ≤ dose <1.0 mg), high (≥1.0 mg), and those spanning multiple categories. No consistent relationship was found between atropine dose and clinical outcomes, such as heart rate response or adverse effects. None of the moderate-dose studies reported worsening bradycardia. Moderate-dose atropine could be safe, and the current practice of using 0.5 mg as an initial dose in Japan, where 0.5 mg/mL prefilled syringes are commercially available, appears clinically reasonable. However, in the absence of high-quality comparative data, future research should apply rigorous study designs to determine the optimal atropine dose in emergency care settings.</p>","PeriodicalId":94305,"journal":{"name":"Circulation reports","volume":"7 11","pages":"1044-1050"},"PeriodicalIF":1.1,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12597395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145491126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Circulation reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1